Karyotyping of circulating tumor cells for predicting chemotherapeutic sensitivity and efficacy in patients with esophageal cancer

[1]  Yu Xu,et al.  Clinicopathological and prognostic significance of circulating tumor cells in patients with esophageal cancer: a meta-analysis , 2018, OncoTargets and therapy.

[2]  O. Gires,et al.  Comprehensive in situ co-detection of aneuploid circulating endothelial and tumor cells , 2017, Scientific Reports.

[3]  L. Shen,et al.  Abstract 3795: Dynamic acquisition of HER2 expression on circulating tumor cells in gastric cancer patients correlates to developing therapeutic resistance , 2017 .

[4]  Jian-Wei Liu,et al.  Prognostic value of circulating tumor cells in esophageal cancer , 2017, World journal of gastroenterology.

[5]  Hung-Ming Wang,et al.  Circulating Tumour Cells as an Independent Prognostic Factor in Patients with Advanced Oesophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy , 2016, Scientific Reports.

[6]  Andrew J. Ewald,et al.  A collective route to metastasis: Seeding by tumor cell clusters , 2016, Science.

[7]  L. Shen,et al.  Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer , 2016, British Journal of Cancer.

[8]  M. Pazzagli,et al.  Single circulating tumor cell sequencing as an advanced tool in cancer management , 2016, Expert review of molecular diagnostics.

[9]  Sridhar Ramaswamy,et al.  RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance , 2015, Science.

[10]  Shengyue Guo,et al.  Comprehensive characterization of chemotherapeutic efficacy on metastases in the established gastric neuroendocrine cancer patient derived xenograft model , 2015, Oncotarget.

[11]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[12]  Q. Zhan,et al.  Chromosomal aneuploidies and combinational fluorescence in situ hybridization probe panels are useful for predicting prognosis for esophageal squamous cell carcinoma , 2015, Journal of Gastroenterology.

[13]  Marius Ilie,et al.  Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine? , 2014, Annals of translational medicine.

[14]  X. Xie,et al.  Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients , 2013, Proceedings of the National Academy of Sciences.

[15]  Zhi Zheng,et al.  Determination of EGFR mutations in single cells microdissected from enriched lung tumor cells in peripheral blood , 2013, Analytical and Bioanalytical Chemistry.

[16]  M. Speicher,et al.  Single circulating tumor cell sequencing for monitoring , 2013, Oncotarget.

[17]  J. Luketich,et al.  Oesophageal carcinoma , 2013, The Lancet.

[18]  J. Izbicki,et al.  Disseminated Tumor Cells in Bone Marrow and the Natural Course of Resected Esophageal Cancer , 2012, Annals of surgery.

[19]  S. Matsusaka,et al.  Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancer , 2011, Cancer science.

[20]  Nicolai J. Birkbak,et al.  Chromosomal instability confers intrinsic multidrug resistance. , 2011, Cancer research.

[21]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[22]  S. Yie,et al.  Detection of survivin-expressing circulating cancer cells in the peripheral blood of patients with esophageal squamous cell carcinoma and its clinical significance , 2009, Clinical & Experimental Metastasis.

[23]  Li Zhang,et al.  Preliminary Investigation of the Clinical Significance of Detecting Circulating Tumor Cells Enriched from Lung Cancer Patients , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[24]  R. Bast,et al.  American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  S. Natsugoe,et al.  Isolated tumour cells in blood and E‐cadherin expression in oesophageal squamous cell cancer , 2007, The British journal of surgery.

[26]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[27]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.